Nordic Life Science 1
TOP STORIES ACQU I SITIONS // AGREEMENTS // COLLA
BORATIONS “Through this initiative, we are seeking a deeper dialogue and broader collaboration aimed at contributing to concrete guidance that benefits individuals, healthcare systems, and society at large. And the partnership between France and Sweden serves as a key foundation.” – Business France, Nordic Infucare and Sanofi COLL ABORATION France and Sweden join forces to boost life science innovation National stakeholders met at the French Residence in Stockholm on April 29 for a roundtable discussion aimed at turning strategic dialogue in life science into concrete guidance for Europe’s innovation capacity. THE MEETING was initiated by Business France, Nordic Infucare and Sanofi. It deepens French-Swedish collaboration under the renewed Strategic Innovation Partnership, with the ambition of strengthening Sweden’s and France’s role as a European hub for medical innovation. The organizers underlined that shared visions now need to translate into practical outcomes to promote population health, patient benefits and future investment in innovation. “Through this initiative, we are seeking a deeper dialogue and broader collaboration aimed at contributing to concrete guidance that benefits individuals, healthcare systems, and society at large. And the partnership between France and Sweden serves as a key foundation,” they stated. “To maintain a strong position, it is essential that we keep up the pace in efforts to safeguard health and investment in medical innovation, and to enable smooth implementation for the people affected in Sweden.” France’s Ambassador to Sweden, H.E. Thierry Carlier, who hosted the discussion, emphasized the importance of cross-border collaboration in an uncertain geopolitical environment. NLS Learn more about Europe's innovation capacity on page 45 MEDTECH Getinge acquires Pennamed Getinge has acquired the UK-based distributor of endoscopic consumables serving National Health Service (NHS) and independent healthcare providers. THE ACQUISITION strengthens Getinge’s offering to endoscopy units across the UK by combining Pennamed’s consumables portfolio and customer relationships with Getinge’s expertise in endoscope reprocessing, infection control, and washer-disinfector technology. With combined annual sales of approximately GBP 130 million and close to 350 employees across Getinge and Pennamed, the UK represents an important part of Getinge’s global operations. “This acquisition strengthens our ability to support UK endoscopy departments with a more complete and connected offering. By combining Pennamed’s consumables expertise with our reprocessing and infection control capabilities, we can deliver greater value to our customers and support the NHS in meeting increasing demand,” says Amy Rothwell, President UK & Ireland, Getinge. NLS EUR 20 MILLION … … is the amount that the European Investment Bank has backed BioLamina with. The financing will be used to expand and scale up production of laminins. 8 | NORDICLIFESCIENCE.ORG PHOTO GETINGE